API Process R&D
Successful API development requires a robust, scalable, and regulatory-compliant manufacturing process that can support drug development from early research to commercial production. As an essential component of Chemistry, Manufacturing, and Controls (CMC) development, API Process R&D focuses on establishing efficient synthetic routes, optimizing critical process parameters, controlling impurities, and ensuring consistent product quality throughout the development lifecycle. Protheragen provides comprehensive API Process R&D services to support pharmaceutical and biotechnology companies in advancing drug candidates from preclinical development to clinical trials and commercialization.
Overview of API Process R&D
API Process R&D (Active Pharmaceutical Ingredient Process Research and Development) is an essential part of pharmaceutical CMC development, focusing on the development, optimization, and scale-up of API manufacturing processes. It bridges the gap between laboratory research and commercial production by establishing reliable, efficient, and scalable processes that meet quality and regulatory requirements.
API Process R&D involves multiple key activities, including synthetic route design, reaction condition optimization, impurity identification and control, purification process development, process safety assessment, and determination of critical process parameters (CPPs). During drug development, these activities help improve process robustness, enhance manufacturing efficiency, and ensure consistent API quality.
From preclinical studies to clinical trials and commercial manufacturing, API Process R&D supports the continuous improvement and transfer of manufacturing processes. It also includes the development of control strategies for starting materials, intermediates, and final APIs to ensure process consistency, regulatory compliance, and long-term production stability.
Fig.1 API development stages, milestones, and chemical development activities. (Krueger J, et al., 2025)
Our Services
Our integrated capabilities cover synthetic route design, process optimization, scale-up development, process safety evaluation, impurity characterization, and GMP manufacturing support. By combining scientific expertise with flexible development strategies, we help clients establish reliable and cost-effective API manufacturing processes while accelerating regulatory submission and commercialization timelines.
Synthetic Route Design & Evaluation
We evaluate and develop practical synthetic routes based on molecular structure, starting material availability, reaction efficiency, impurity risks, safety considerations, and scalability.
Key activities include:
- Synthetic route design and evaluation
- Starting material and intermediate assessment
- Reaction condition screening
- Evaluation of alternative synthetic pathways
- Assessment of scalability and manufacturing feasibility
- Route optimization for yield, purity, cost, and process robustness
Process Development & Optimization
Our process development team develops and optimizes manufacturing processes to achieve consistent product quality and reliable process performance.
Services include:
- Reaction condition optimization
- Reagent, catalyst, and solvent screening
- Reaction parameter optimization
- Work-up and purification optimization
- Crystallization and isolation process development
- Yield and purity improvement
- Process robustness assessment
- Development of fit-for-purpose manufacturing processes
Process Safety Evaluation
Process safety is incorporated into API development to identify potential risks before scale-up and manufacturing.
The evaluation may include:
- Reaction hazard assessment
- Thermal and chemical stability assessment
- Identification of potentially hazardous reaction conditions
- Evaluation of high-temperature and low-temperature reactions
- Assessment of reaction and process-related risks
- Recommendations for safer and more controllable process conditions
Our platform can support a broad range of chemical transformations, including conventional reactions, asymmetric catalytic hydrogenation, high-temperature reactions, and low-temperature reactions.
Scale-Up & Manufacturing Process Development
Following laboratory-scale process development, we support the transition toward larger-scale manufacturing by evaluating process performance and identifying scale-dependent risks.
Key activities include:
- Laboratory-to-pilot scale process transfer
- Scale-up parameter evaluation
- Critical process parameter identification
- Process reproducibility assessment
- Manufacturing process optimization
- Process transfer and technical support
- Support for GMP manufacturing, where applicable
Critical Process Parameter & Process Control Development
We identify and evaluate process parameters that may have a significant impact on API quality and process performance.
Activities include:
- Identification of critical process parameters (CPPs)
- Evaluation of parameter–quality relationships
- Establishment of appropriate process control strategies
- Control of starting materials and intermediates
- In-process control considerations
- Process monitoring and optimization
This approach helps establish a more consistent and controllable API manufacturing process for subsequent scale-up and commercial production.
Impurity Preparation & Purification
Impurity management is integrated into API process development to support process understanding, analytical development, and quality assessment.
Services include:
- Process-related impurity preparation
- Impurity separation and purification
- Isolation of impurities from reaction mixtures
- Impurity structure characterization support
- Preparation of impurity reference materials
- Investigation of impurity formation pathways
- Support for impurity control strategy development
Continuous Process Optimization
For projects progressing toward commercialization, we support ongoing process improvements to enhance manufacturing efficiency, robustness, and sustainability.
Optimization may focus on:
- Improving reaction yield and selectivity
- Reducing impurities and by-products
- Improving purification efficiency
- Reducing solvent and reagent consumption
- Improving process safety
- Simplifying manufacturing operations
- Reducing production cost
- Enhancing process robustness and scalability
API Process R&D Across the Development Lifecycle
Our API process development services can be tailored to different stages of drug development:
- Preclinical: Synthetic route evaluation, process feasibility assessment, and initial process development
- Clinical Development: Process optimization, impurity control, scale-up support, and process characterization
- Commercialization: Manufacturing process refinement, process transfer, process validation support, and continuous process improvement
API Development Across the CMC Lifecycle
API process development evolves throughout the CMC lifecycle, with development priorities changing from route feasibility and material supply in early development to process robustness, scalability, and commercial manufacturing in later stages. Protheragen provides stage-appropriate API process development support from preclinical studies through clinical development and commercialization.
| CMC Development Stage |
Key API Process R&D Activities |
Development Focus |
| Preclinical Development |
Synthetic route evaluation, route design, reaction feasibility studies, preliminary process development, and initial impurity assessment |
Establish a feasible and efficient synthetic route and generate API material for preclinical studies |
| Phase I–II Clinical Development |
Process optimization, reaction condition refinement, impurity investigation, purification development, and laboratory-to-larger-scale process development |
Improve yield, purity, process reproducibility, and manufacturing feasibility for clinical supply |
| Phase III Development |
Process refinement, scale-up studies, critical process parameter identification, impurity control, and process control strategy development |
Establish a robust, reproducible, and scalable process suitable for late-stage clinical and GMP manufacturing |
| Commercialization |
Process transfer, manufacturing support, process performance evaluation, continuous process improvement, and manufacturing troubleshooting |
Support reliable commercial production, consistent API quality, manufacturing efficiency, and long-term supply |
This lifecycle-based approach enables API processes to be progressively developed and optimized as development programs advance, helping maintain process continuity while addressing the increasing requirements for quality, scalability, process robustness, and regulatory compliance.
Process Development Capabilities
API process development requires a broad range of chemical and engineering capabilities to establish efficient, robust, and scalable manufacturing processes. Protheragen supports the development and optimization of API processes involving diverse reaction conditions and synthesis challenges, with a focus on improving process efficiency, product quality, safety, and scalability.
Synthetic Route Design & Optimization
Design and evaluate practical synthetic routes, optimize reaction sequences and conditions, and improve yield, efficiency, and overall process feasibility.
Diverse Reaction Development
Develop and optimize various chemical processes, including conventional reactions, asymmetric catalytic hydrogenation, high-temperature reactions, and low-temperature reactions.
Isolation, Purification & Impurity Control
Develop isolation and purification processes while identifying, controlling, and removing process-related impurities to achieve the required API quality.
Process Safety & Parameter Optimization
Evaluate process risks and optimize critical parameters such as temperature, pressure, reaction time, solvent, concentration, and reagent ratios to improve process robustness and safety.
Scale-Up & Process Transfer
Adapt laboratory processes for larger-scale manufacturing, evaluate scale-dependent process parameters, and support reliable technology transfer to GMP production.
Process Control Strategy
Identify critical process parameters (CPPs) and establish appropriate control strategies for starting materials, intermediates, and APIs to ensure consistent product quality.
Why Choose Protheragen
- Lifecycle-Oriented Development
Support is available from early-stage process development through clinical development and commercial manufacturing.
Processes are developed with scalability, reproducibility, manufacturing feasibility, and long-term process performance in mind.
- Integrated Impurity & Quality Support
Impurity preparation, process understanding, analytical development, and quality research can be coordinated within the broader CMC program.
- Process Safety & Robustness
Process safety and critical process parameters are considered during development to reduce scale-up and manufacturing risks.
Services can be provided as individual process development activities or integrated into a broader CMC development program.
- Supporting Your API Development Journey
From synthetic route design to scalable manufacturing processes, our API Process R&D services help transform laboratory chemistry into robust and commercially relevant manufacturing processes.
From early-stage route development to scale-up and commercial manufacturing support, Protheragen provides integrated API Process R&D solutions designed to build robust, scalable, and efficient manufacturing processes. By combining process optimization, impurity control, process safety assessment, and manufacturing-focused development, we help clients advance API programs with greater process reliability and confidence throughout the CMC lifecycle. Contact us to discuss your API development requirements and build a fit-for-purpose process development strategy.
Reference
- Krueger J, et al. "Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists" Angew Chem Int Ed Engl. 2025; 64(19): e202420719.
